Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Present at the Deutsche Bank Healthcare Conference

NOVATO, Calif., May 8, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Hank Fuchs, M.D., Chief Medical Officer at BioMarin, will present a company update at...
May 08, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Present at the Baird Growth Stock Conference

NOVATO, Calif., May 8, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Hank Fuchs, M.D., Chief Medical Officer at BioMarin, will present a company update at...
April 26, 2012 16:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Announces First Quarter 2012 Financial Results

Strong Commercial Performance Supporting Development of Five New Chemical Entities With Key Clinical Readouts by the End of 2012 Conference Call and Webcast to Be Held Today at 5:00 p.m....
April 05, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Host First Quarter 2012 Financial Results Conference Call and Webcast on Thursday, April 26 at 5:00 p.m. ET

NOVATO, Calif., April 5, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer of BioMarin, will host a...
March 08, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Completes Enrollment for Phase 3 Trial for GALNS for the Treatment of MPS IVA

Largest Phase 3 ERT Study to Date in a Lysosomal Storage Disease Results Expected in the Fourth Quarter of 2012 NOVATO, Calif., March 8, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc....
March 06, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Present at the Barclays Global Healthcare Conference

NOVATO, Calif., March 6, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Joshua Grass, Senior Vice President of Corporate and Business Development at BioMarin,...
February 22, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Present at the RBC Global Healthcare Conference

NOVATO, Calif., Feb. 22, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer of BioMarin, will present a...
February 22, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Present at the Citi Global Health Care Conference

NOVATO, Calif., Feb. 22, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer of BioMarin, will present a...
February 21, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Announces Chief Financial Officer Jeffrey Cooper to Leave the Company

NOVATO, Calif., Feb. 21, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today that Jeffrey Cooper, Senior Vice President and Chief Financial Officer, plans to leave the...
February 16, 2012 16:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Initiates Phase 1 Trial for BMN-111 for the Treatment of Achondroplasia

NOVATO, Calif., Feb. 16, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today the initiation of a Phase 1 study in healthy volunteers for BMN-111, an analog of C-type...